Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategy.
Wu T, Zhang Z, Gong G, Du Z, Xu Y, Yu S, Ma F, Zhang X, Wang Y, Chen H, Wu S, Xu X, Qiu Z, Li Z, Wu H, Bian J, Wang J.
Wu T, et al.
Eur J Med Chem. 2023 Nov 15;260:115774. doi: 10.1016/j.ejmech.2023.115774. Epub 2023 Sep 1.
Eur J Med Chem. 2023.
PMID: 37672930